<link rel="stylesheet" href="styles.496d4e7d62ff4fd0.css">
Repository logo
KNOWLEDGEREPOSITORY

Publication:
Relapse following chemotherapy of human and animal African Trypanosomoses: A Review

creativeworkseries.issn0378-9721
dc.contributor.authorOsue, H. O.
dc.coverage.spatialNigeria
dc.date.accessioned2026-10-25T11:33:55Z
dc.date.issued2017-12
dc.description.abstractAn effective treatment regimen depends on detecting cases of African trypanosomosis, is a highly desirable and dependable control options. The last new veterinary drug, diminazene aceturate (Berenil) and that for treating human African trypanosomosis, alpha-Difluoromethylornithine or eflorthine (α-DFMO) that were patented 55 and 40 years ago, respectively showed the dearth of anti-trypanosome drugs. A major setback is ineffectiveness of treatment often attributed to the following factors: (i) wide spread resistance, which cut across the disease ecological areas involving all the pathogenic trypanosome species and available trypanocides. The increasing reports of multiple and cross resistance could worsen the already deplorable situation with very few drugs of choice, and (ii) parasites are shielded from trypanocidal drug actions in “privileged” sites; eyes, testes adipose tissue and brain. Advances in molecular biology have afforded the application of polymorphism to identify drug resistant genes. Lately, RNA interference used in gene silencing have allowed more insight into mode of drug actions and mechanism of resistance. Most trypanocides (excluding tryparsamide, melamingly arsenicals, nitrofuran and DFMO cannot cross the bloodtight (the blood-brain/blood-cerebrospinal fluid) barriers. Similarly, the lack of detectable levels of drugs in adipose tissue, spleen, skeletal muscle and lungs could result in relapse. Occult infection with amastigote and sphaeromastigote stages of Trypanosoma brucei lodged in the choroids plexus has remained controversial. Strict adherence to established protocol for rational drug use has been advocated as possible panacea to limit emergence and spread of induced drug resistance. Effective management of HAT cases will depend on accurate diagnosis and clinical staging of the disease, will inform using pentamidine and suramin or merlasoprol or a combination of these drugs for early and late stage infections. Other operational factors that promote occurrence of relapse includes increase in defective or adulterated drugs, inappropriate handling resulting in under dosage and pharmacokinetic limitations. The areas requiring research attentions and ways to minimize relapse are highlighted.en
dc.format.extent21 p.
dc.identifier.citationOsue, H. O. (2017). Relapse following chemotherapy of human and animal African Trypanosomoses: A Review. Bulletin of Animal Health and Production in Africa, 65(4), 777-797.
dc.identifier.issn0378-9721
dc.identifier.urihttps://repository.otcloud.co.ke/handle/123456789/2242
dc.language.isoen
dc.publisherAfrican Union Inter-African Bureau for Animal Resources (AU-IBAR)
dc.subjectCryptic infectionen
dc.subjectDrug-resistanceen
dc.subjectPrivileged sitesen
dc.subjectRecrudescenceen
dc.subjectRelapseen
dc.subjectTrypanocidesen
dc.subjectTrypanosomosisen
dc.subject.auibarAnimal Health::Endemic and Production Diseases::Trypanosomosis and Tsetse Control
dc.titleRelapse following chemotherapy of human and animal African Trypanosomoses: A Reviewen
dc.typeJournal article
dspace.entity.typePublication
journal.titleBulletin of Animal Health and Production in Africa
journalvolume.identifier.nameBulletin of Animal Health and Production in Africa, Vol. 65 (2017)
oaire.citation.endPage797
oaire.citation.issue4
oaire.citation.startPage777
oaire.citation.titleBulletin of Animal Health and Production in Africa
oaire.citation.volume65
relation.isJournalIssueOfPublicationa36ad3de-8034-4955-bb94-f5cda46d82a3
relation.isJournalIssueOfPublication.latestForDiscoverya36ad3de-8034-4955-bb94-f5cda46d82a3
relation.isJournalOfPublication86d57c18-eaeb-45a8-95f1-19a15f6db0c8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BAHPA_65-4_p777-797_Osue.pdf
Size:
221.86 KB
Format:
Adobe Portable Document Format
Description:
Article PDF, pages 777-797 of the issue